Results 211 to 220 of about 80,623 (257)

Enalapril and Pregnancy-Induced Hypertension

Annals of Internal Medicine, 1988
Excerpt To the editor: Shubiger and colleagues (1) have confirmed that administering angiotensin-converting enzyme inhibitors to pregnant women can provoke renal failure in the newborn.
M D, Lindheimer, W M, Barron
openaire   +2 more sources

Anesthesia for Pregnancy-Induced Hypertension

Clinics in Perinatology, 1982
Women with severe pregnancy-induced hypertension are often critically ill; their fetuses are usually compromised. An ideal anesthetic method does not exist for the parturient with severe hypertension, hypovolemia, and organ failure. Optimal anesthetic results depend upon thorough preanesthetic evaluation and best medical control of pathophysiology ...
A S, Wheeler, B A, Harris
openaire   +2 more sources

The Endocrinology of Pregnancy-Induced Hypertension

Clinics in Perinatology, 1983
Discussed in this article are the effects of pregnancy-induced hypertension on the renin-angiotensin-aldosterone system; the possible role of prostanoids, deoxycorticosterone, and deoxycorticosterone sulfate in blood pressure control; and the effect of pregnancy-induced hypertension upon the endocrinology of the maternal-fetal-placental unit.
B R, Carr, N F, Gant
openaire   +2 more sources

Labetalol pharmacokinetics in pregnancy-induced hypertension

American Journal of Obstetrics and Gynecology, 1990
Pharmacokinetic parameters of oral labetalol were studied in eight women with pregnancy-induced hypertension in the third trimester of pregnancy. Labetalol exhibited rapid absorption; peak serum concentrations of 881 +/- 219 ng/ml occurred at 20 minutes after labetalol ingestion.
R C, Rogers, B M, Sibai, W D, Whybrew
openaire   +2 more sources

Neutrophil activation in pregnancy‐induced hypertension

BJOG: An International Journal of Obstetrics & Gynaecology, 1989
Summary. Human neutrophil elastase may be a major mediator of vascular damage and could contribute to the vascular damage seen in women with pregnancy‐induced hypertension (PTH). Elevated plasma levels of this substance will reflect neutrophil activation in vivo.
I A, Greer, N G, Haddad, J, Dawes, F D, Johnstone, A A, Calder   +4 more
openaire   +2 more sources

PLASMA PROLACTIN IN PREGNANCY INDUCED HYPERTENSION

BJOG: An International Journal of Obstetrics & Gynaecology, 1978
SummaryIn a prospective study, plasma prolactin concentration at 37 to 41 weeks gestation in 45 primigravidae showed a significant correlation with maximal rise in diastolic blood pressure between levels at 7 to 16 weeks and those measured between 28 weeks and delivery.
D M, Jenkins, L A, Perry
openaire   +2 more sources

On the Alert for Pregnancy-Induced Hypertension

Home Healthcare Nurse: The Journal for the Home Care and Hospice Professional, 2001
Increasing the skills of maternal-child home care nurses can identify early incidences of pregnancy-induced hypertension (PIH) for medical intervention, resulting in the prevention of hospitalization and decrease of potential complications. This article describes one agency's approach to teaching staff these important skills.
openaire   +2 more sources

Pregnancy-induced hypertension

1986
The best approach to the management of pregnancy-induced hypertension (PIH) would be its prevention (Table 17.1). Unfortunately, this goal will continue to elude us until we understand the primary pathogenesis of this condition. Some hypotheses are beginning to emerge.
F. Broughton Pipkin, E. M. Symonds
openaire   +1 more source

Transient blindness in pregnancy induced hypertension

International Journal of Gynecology & Obstetrics, 1989
AbstractTransient blindness associated with pregnancy induced hypertension without neurological symptoms is a rare phenomenon. The blindness in these cases is postulated to be of “cortical blindness”. Two such cases occurring immediately after childbirth are presented. The ophthalmic manifestations of this complication of pregnancy induced hypertension
S, Nalliah, A S, Thavarashah
openaire   +2 more sources

Pharmacologic Therapy for Pregnancy-Induced Hypertension

The Journal of Perinatal & Neonatal Nursing, 1996
Complications of pregnancy-induced hypertension (PIH) remain a leading cause of maternal mortality in the United States. The etiology of the disease is not fully understood, but pathologic effects of PIH on maternal organ systems are well documented.
M C, Sisson, P M, Sauer
openaire   +2 more sources